$ARVINDREM what a drop of stock price! I have never seen such a crazy stock!
Flor Crowley 05:30 PM 05-04-2015
$ARVINDREM haha, you say sell? EBITDA margin stabilized at 20% in 2013-14, revenue grew 30-51% in 2012-14, EV/EBITDA = 4.1 and with this growth it would be 7-8 on the current market. Debt/EBITDA = 3.5, so Equity/EBITDA=0.6
If the stock grow even to 5 EV/EBITDA, Equity/EBITDA grows to 1.5 which is 150% stock growth #buy
Rajesh Khattar 10:25 PM 04-04-2015
$ARVINDREM it bounced back a bit, so use the opportunity and #sell the stock, it's too expensive versus it's profits/cash flows
Amir Uttal 06:07 PM 18-03-2015
$ARVINDREM This is actually good for shareholders - whey borrow debt at ~8.5% after-tax rate to invest in the business with 12.7% Return on Capital #bullish
Amir Uttal 05:46 PM 18-03-2015
$ARVINDREM they simply use the debt to partly finance their revenue and EBITDA growth. The debt was used to invest into Capex and Working Capital. For example in 2014 with debt increase of 120 Capex was 24 + WC increase was 253 = 277, the rest came from EBITDA which was 184 #bullish
Barry Gardiner 05:39 PM 16-03-2015
$ARVINDREM the debt is huge, with market cap at 120 crore debt is 641 the company may simply go bankrupt with the stock going to 0 in this case #bearish
Niten 05:21 PM 12-12-2014
$ARVINDREM price target is 40, but for long term investors only... not a good play for short term traders #buy
Arvind Remedies Limited manufactures and markets pharmaceutical products in India and internationally. The company provides allopathic products, including ethical products comprising analgesic/anti-inflammatory products, anti-infectives, antioxidants, anti rheumatic and anti spasmodic products, cough expectorants/nasal decongestants, haematinics, nutritional supplements, vitamins, hyperacidity and reflux ulcers, topical antipruritics, gonadal hormones, and anti asthmatics; branded generic products; and generic products. It also offers ayurvedic products, such as Artin oil for myalgias, arthralgias, frozen shoulders, stiff joints, arthritis, and musculoskeletal disorders of varied aetiology; Hygenex for leucorrhoea, non specific vaginitis, pruritis, dyspareunia, cervicitis, etc.; Pankare for diabetes mellitus; Solufat for hyperlipidaemias of varied aetiology; Sorexil for various skin ulcers bedsores, varicose ulcers, ulcers of insensitive foot, diabetic ulcers, and cuts and wounds; Stresof for conditions related to stress, aging and convalescence, and insomnia general debility and vitaliser; and Utritone for the treatment of leucorrhoea, non specific verginitis, pruritis, dysparunea, cervicitis, dysmenorrhoea, and oligomenorrhagea. In addition, the company provides contract manufacturing services. It serves defence establishments, ESI, CGHS, central and state government institutions, public sector companies, P&T, railways, and world bank projects. The company was incorporated in 1988 and is based in Chennai, India.